You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Multiple Sclerosis Pediatric MS NeuroVax Vaccine Therapeutic

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Program Study for Improvement of Gait in People With Multiple

Not yet recruiting
  • Gait Impairment Due to Mild/Moderate Multiple Sclerosis (MS)
  • PoNS®
  • (no location specified)
Jun 23, 2022

Multiple Sclerosis Trial (Endeavor™)

Not yet recruiting
  • Multiple Sclerosis
  • Action Video Game Treatment
  • New York, New York
    NYU Langone Health - Ambulatory Care Center
Oct 17, 2022

Multiple Sclerosis Trial in Ankara (line dancing)

Completed
  • Multiple Sclerosis
  • line dancing
  • Ankara, Turkey
    Hacettepe University
Apr 4, 2022

Pediatric Multiple Sclerosis Trial in New York (ABMT mobile application)

Completed
  • Pediatric Multiple Sclerosis
  • ABMT mobile application
  • New York, New York
    NYU Langone Health
Mar 1, 2022

COVID-19 Vaccine Response in Treated MS Patients

Recruiting
  • Multiple Sclerosis
  • Healthy
  • Blood draw
  • Boston, Massachusetts
    Brigham MS Center
Jul 26, 2022

Mechanistic Studies of Teriflunomide in RRMS

Active, not recruiting
  • Relapsing Remitting Multiple Sclerosis
  • Ann Arbor, Michigan
    University of Michigan
Jul 27, 2022

Multiple Sclerosis Trial in San Diego (NeuroVax, IFA Incomplete Freund's Adjuvant)

Not yet recruiting
  • Multiple Sclerosis
  • NeuroVax
  • IFA Incomplete Freund's Adjuvant
  • San Diego, California
    CRO
Mar 30, 2020

Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Pemphigus Vulgaris Trial in United States (Moderna mRNA-1273,

Recruiting
  • Rheumatoid Arthritis
  • +8 more
  • Moderna mRNA-1273
  • +5 more
  • Los Angeles, California
  • +24 more
Aug 17, 2022

COVID-19 Vaccine Biomarker Study in Multiple Sclerosis

Recruiting
  • Multiple Sclerosis
  • COVID-19
    • New York, New York
      Columbia University Irving Medical Center
    Nov 12, 2021

    Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting Trial in Germany, United States (Tetanus, diphtheria, and acellular

    Recruiting
    • Multiple Sclerosis
    • Multiple Sclerosis, Relapsing-Remitting
    • Tetanus, diphtheria, and acellular pertussis vaccine
    • +2 more
    • Palo Alto, California
    • +47 more
    Jun 24, 2022

    Multiple Sclerosis Trial in Italy, Poland, United States (Ocrelizumab)

    Recruiting
    • Multiple Sclerosis
    • Loma Linda, California
    • +22 more
    Jan 13, 2023

    Multiple Sclerosis, Fatigue Trial in Berlin (Sleep medical treatment)

    Terminated
    • Multiple Sclerosis
    • Fatigue
    • Sleep medical treatment
    • Berlin, Germany
      Charité University Medicine Berlin
    Jul 28, 2021

    Multiple Sclerosis, Relapsing-Remitting Trial in Canada, United States (23-PPV, 13-PCV Booster, Influenza Vaccine)

    Completed
    Has Results
    • Multiple Sclerosis, Relapsing-Remitting
    • 23-PPV
    • +5 more
    • Cullman, Alabama
    • +21 more
    Apr 4, 2022

    Multiple Sclerosis (MS) Trial in Worldwide (Fingolimod, Ofatumumab, Siponimod)

    Recruiting
    • Multiple Sclerosis (MS)
    • Little Rock, Arkansas
    • +55 more
    Jan 13, 2023

    Secondary Progress Multiple Sclerosis, Multiple Sclerosis Trial in San Diego (NeuroVax, IFA Placebo)

    Recruiting
    • Secondary Progress Multiple Sclerosis
    • Multiple Sclerosis
    • NeuroVax
    • IFA Placebo
    • San Diego, California
      CRO
    Mar 9, 2020

    Suboptimally Controlled Participants Previously Taking Oral or

    Recruiting
    • Multiple Sclerosis
    • Cladribine Tablets
    • Cullman, Alabama
    • +66 more
    Nov 29, 2022

    Multiple Sclerosis Trial in San Diego (NeuroVax, IFA Incomplete Freund's Adjuvant)

    Unknown status
    • Multiple Sclerosis
    • NeuroVax
    • IFA Incomplete Freund's Adjuvant
    • San Diego, California
      CRO
    Mar 9, 2020

    Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (Ocrelizumab, Ocrelizumab Placebo, Fingolimod)

    Recruiting
    • Relapsing-Remitting Multiple Sclerosis
    • La Jolla, California
    • +66 more
    Jan 27, 2023

    Obesity and Pediatric Multiple Sclerosis

    Recruiting
    • Multiple Sclerosis
      • Philadelphia, Pennsylvania
      • +1 more
      Oct 31, 2022

      Multiple Sclerosis Trial in Worldwide (Interferon beta-1a, Fingolimod, Placebo capsule)

      Recruiting
      Has Results
      • Multiple Sclerosis
      • Interferon beta-1a
      • +3 more
      • Birmingham, Alabama
      • +106 more
      Jan 13, 2023

      MS Trial in Giza (strengthening ex with BFR training, strengthening ex)

      Recruiting
      • MS
      • strengthening ex with BFR training
      • strengthening ex
      • Giza, Egypt
        Faculty of physical therapy
      Nov 16, 2023

      Multiple Sclerosis Trial (Aerobic training, Balance training)

      Completed
      • Multiple Sclerosis
      • Aerobic training
      • Balance training
      • (no location specified)
      Sep 18, 2023

      Lipid Mediators in Multiple Sclerosis

      Completed
      • Multiple Sclerosis
      • Samples
      • Pozzilli, Isernia, Italy
        IRCCS Neuromed
      Nov 22, 2022

      d in the Treatment of Multiple Sclerosis

      Not yet recruiting
      • Multiple Sclerosis
      • Measurement of concentrations of orally-used DMDs
      • +3 more
      • Ostrava, Moravian-Silesian Region, Czechia
      • +1 more
      Dec 5, 2022

      Multiple Sclerosis, Insomnia Trial (Digital Cognitive Behavioral Therapy for Insomnia (dCBT-I), Digital patient education about

      Not yet recruiting
      • Multiple Sclerosis
      • Insomnia
      • Digital Cognitive Behavioral Therapy for Insomnia (dCBT-I)
      • Digital patient education about insomnia (PE)
      • (no location specified)
      Oct 27, 2023